Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Brain Communications|March 2, 2023
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension studyDarin T Okuda, Daniel Kantor, Mark Jaros, et al.Brain Communications|December 15, 2022
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trialDarin T Okuda, Daniel Kantor, Mark Jaros, et al.Multiple Sclerosis and Related Disorders|July 11, 2024
Underdosed generic specialty medications: A prescription for patient harm?Darin T Okuda, Katy W Burgess, Tatum M Moog, et al.Neurologic Clinics|November 22, 2017
Anomalies Characteristic of Central Nervous System Demyelination: Radiologically Isolated SyndromeChristine Lebrun, Orhun H Kantarci, Aksel Siva, et al.Journal of Health Economics and Outcomes Research|October 31, 2024
Costs of Potential Medication Wastage Due to Switching Treatment Among People With Multiple SclerosisDarin T Okuda, Achal Patel, Robert Schuldt, et al.Journal of Child Neurology|May 4, 2004
Naegleria fowleri hemorrhagic meningoencephalitis: report of two fatalities in childrenDarin T Okuda, Hank J Hanna, Stephen W Coons, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2005
Acute pathological laughterDarin T Okuda, Abraham S C Chyung, Cynthia T Chin, et al.Annals of Clinical and Translational Neurology|October 31, 2014
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesionsDarin T Okuda, Kara Melmed, Takashi Matsuwaki, et al.Therapeutic Advances in Neurological Disorders|March 22, 2012
From injection therapies to natalizumab: views on the treatment of multiple sclerosisRoberto Bomprezzi, Darin T Okuda, Yazan J Alderazi, et al.Journal of Neurology|April 13, 2023
High-efficacy therapies reduce clinical and radiological events more effectively than traditional treatments in neuromyelitis optica spectrum disorderTatum M Moog, Alexander D Smith, Katy W Burgess, et al.Pageof 11